共 105 条
[1]
Kim S-Y(2005)Screening of brain metastasis with limited Magnetic Resonance Imaging (MRI): clinical implications of using limited brain MRI during initial staging for non-small cell lung cancer patients J Korean Med Sci 20 121-126
[2]
Kim J-S(2003)MR-imaging of the brain of neurologic asymptomatic patients with large cell or adenocarcinoma of the lung. Does it influence prognosis and treatment? Lung Cancer 42 189-193
[3]
Park H-S(2015)Non-small cell lung cancer patients with brain metastases treated with first-line platinum-doublet chemotherapy: analysis from the European FRAME study Lung Cancer 90 427-432
[4]
Hochstenbag MMH(2017)Epidermal growth factor receptor mutational status and brain metastases in non–small-cell lung cancer JGO 3 208-217
[5]
Twijnstra A(2016)A retrospective analysis in patients with EGFR-mutant lung adenocarcinoma: is EGFR mutation associated with a higher incidence of brain metastasis? Oncotarget 7 56998-57010
[6]
Hofman P(2017)Correlation between EGFR mutation status and the incidence of brain metastases in patients with non-small cell lung cancer J Thorac Dis 9 2510-2520
[7]
Moro-Sibilot D(2019)Long-term outcomes from the randomized phase II study of nivolumab (nivo) or nivo plus ipilimumab (ipi) in patients (pts) with melanoma brain metastases (mets): Anti-PD1 brain collaboration (ABC) Ann Oncol 30 v534-60
[8]
Smit E(2019)Long-term survival of patients with melanoma with active brain metastases treated with Pembrolizumab on a phase II trial J Clin Oncol 37 52-465
[9]
de Castro CJ(2012)Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial Lancet Oncol 13 459-730
[10]
Bhatt VR(2018)Combined nivolumab and ipilimumab in melanoma metastatic to the brain N Engl J Med 379 722-873